AZ
AZLGF.US Azelis Group NV
- Market cap
- USD 3.21B
- P/E
- 23.9x
- P/B
- 1.02x
- ROE
- 12.0%
- Dividend yield
- 1.96%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is AZLGF.US undervalued?
Graham numberAZLGF.US trades 4.2% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Azelis Group NV fundamental analysis
No fundamental analysis for Azelis Group NV yet.
Azelis Group NV stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Azelis Group NV
Azelis Group NV engages in the distribution of specialty chemicals and food ingredients. The company provides specialty chemical products used in the life sciences, such as personal care, home care, industrial cleaning, pharmaceuticals, healthcare, food and nutrition, animal nutrition, agricultural environmental, flavours and fragrances, and nutraceuticals solutions; and industrial chemicals industry, including CASE, advanced materials and additives, lubricants, metalworking…
Full company profileAzelis Group NV financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Azelis Group NV annual financial statements
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 257M | 2.10B | 2.22B | 2.83B | 4.12B | 4.15B | 4.24B | 4.11B | 8.65B |
| Gross Profit | 26.5M | 434M | 524M | 642M | 961M | 961M | 1.03B | 500M | 1.14B |
| Operating Income | 9.55M | 129M | 147M | 208M | 388M | 387M | 386M | 293M | 703M |
| EBITDA | -14.1M | 163M | 193M | 229M | 438M | 446M | 477M | 419M | 953M |
| Net Income | -21.5M | 48.0M | 71.0M | 67.8M | 213M | 178M | 181M | 111M | 340M |
| EPS | -0.09 | 0.21 | 0.30 | 0.29 | 0.91 | 0.74 | 0.74 | 0.46 | 1.40 |
| Balance Sheet | |||||||||
| Total Assets | 2.63B | 2.88B | 2.95B | 3.98B | 4.98B | 5.57B | 5.76B | 5.40B | 5.71B |
| Total Liabilities | 1.45B | 1.65B | 1.74B | 1.73B | 2.54B | 2.90B | 2.84B | 2.69B | 2.86B |
| Shareholders' Equity | 1.18B | 1.23B | 1.22B | 2.23B | 2.38B | 2.59B | 2.88B | 2.69B | 2.83B |
| Cash & Short-term Investments | 81.6M | 104M | 163M | 143M | 268M | 485M | 305M | 263M | 245M |
| Total Debt | 1,000M | 1.21B | 1.29B | 1.01B | 1.44B | 1.78B | 1.84B | 1.87B | 1.84B |
| Cash Flow | |||||||||
| Operating Cash Flow | 61.7M | 75.9M | 117M | 162M | 369M | 525M | 323M | 311M | 233M |
| Capital Expenditure | 3.81M | 12.3M | 12.1M | 18.3M | 18.4M | 15.5M | 13.9M | 24.9M | 18.0M |
| Free Cash Flow | 57.9M | 63.6M | 105M | 71.6M | 350M | 510M | 309M | 286M | 215M |
| Ratios | |||||||||
| ROE | -1.8% | 3.9% | 5.8% | 3.0% | 8.9% | 6.9% | 6.3% | 4.1% | 12.0% |
| ROA | -0.8% | 1.7% | 2.4% | 1.7% | 4.3% | 3.2% | 3.1% | 2.1% | 6.0% |
| Net Profit Margin | -8.4% | 2.3% | 3.2% | 2.4% | 5.2% | 4.3% | 4.3% | 2.7% | 3.9% |
| Debt to Equity | 0.85x | 0.98x | 1.06x | 0.45x | 0.60x | 0.69x | 0.64x | 0.70x | 0.65x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Azelis Group NV dividends
- Dividend yield
- 1.96%
- Forward dividend
- 0.26 USD
- Payout ratio
- 49.4%
- Ex-dividend date
- Jun 29, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 54.9M | 0.23 | 49.4% |
| 2024 | EUR 53.3M | 0.22 | 29.5% |
| 2023 | EUR 67.8M | 0.28 | 38.1% |
| 2022 | EUR 7.01M | 0.03 | 3.3% |
| 2021 | USD 7.01M | 0.03 | 10.3% |
| 2020 | USD 7.01M | 0.03 | 9.9% |
| 2019 | USD 7.01M | 0.03 | 14.6% |
| 2018 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Azelis Group NV
- Insiders 5.10%
- Institutions 65.60%
- Public & others 29.30%
- Shares outstanding 243M
- Free float 195M
Azelis Group NV company profile
- Company name
- Azelis Group NV
- Ticker
- AZLGF.US
- Exchange
- USA Stocks
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 3,998
- Fiscal year end
- December
- Address
- Posthofbrug 12, Antwerp, Belgium, 2600
- Phone
- 32 3 613 01 20
- Website
- azelis.com
About Azelis Group NV
Azelis Group NV engages in the distribution of specialty chemicals and food ingredients. The company provides specialty chemical products used in the life sciences, such as personal care, home care, industrial cleaning, pharmaceuticals, healthcare, food and nutrition, animal nutrition, agricultural environmental, flavours and fragrances, and nutraceuticals solutions; and industrial chemicals industry, including CASE, advanced materials and additives, lubricants, metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper markets. It operates in Europe, Middle East, and Africa, as well as the Americas and the Asia-Pacific. Azelis Group NV was founded in 1996 and is headquartered in Antwerp, Belgium.
Azelis Group NV management
8- Ms. Anna BertonaGroup CEO & Executive Director · born 1967
- Mr. Boris Cambon-LalanneGroup CFO & Director
- Mr. Gerrit De VosGroup General Counsel, Chief Compliance Officer & Company Secretary
- Ms. Karine ParentGroup HR Director
- Ms. Pamela AntaySenior Vice President of Equity & Credit Relations
- Mr. Todd CottrellChief Executive Officer of Americas · born 1975
- Ms. Evy HellinckxChief Executive Officer of EMEA · born 1982
- Mr. Benoit FritzChief Executive Officer of Asia Pacific · born 1973